Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Solana Company (HSDT : NSDQ)

• Company Description    Helius Medical Technologies Inc. is a specialty medical device company. It is focused on the development and regulatory approval of its non-invasive neurostimulation device called PoNS. The Company is nearing clinical trials for balance disorders in TBI patients and for the treatment of MS. Helius Medical Technologies, Inc. is based in Newtown, Pennsylvania. Number of Employees: 21

• Price / Volume Information    Yesterday's Closing Price: $2.29 Daily Weekly Monthly 20 Day Moving Average: 225,629 shares Shares Outstanding: 58.39 (millions) Market Capitalization: $133.71 (millions) Beta: 1.06 52 Week High: $217.63 52 Week Low: $1.59 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 11.16% 5.73% 12 Week 8.53% 0.33% Year To Date -20.76% -24.92%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 642 NEWTOWN YARDLEY ROAD SUITE 100 - NEWTOWN,PA 18940 USA ph: 215-944-6100 fax: - ir@solanacompany.co http://www.solanacompany.co

• General Corporate Information    Officers Dane C. Andreeff - President; Chief Executive Officer and Director Joseph Chee - Executive Chairman and Director Jeffrey S. Mathiesen - Chief Financial Officer;Treasurer and Secretary Paul Buckman - Director Blane Walter - Director Peer Information Solana Company (ABMD) Solana Company (DMDS) Solana Company (CPWY.) Solana Company (EQUR) Solana Company (ECIA) Solana Company (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 42328V876 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 58.39 Most Recent Split Date: 7.00 (0.02:1) Beta: 1.06 Market Capitalization: $133.71 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.02 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.09 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.68 Price/Cash Flow: - Price / Sales: 13.94 EPS Growth vs. Year Ago Period: 99.92% vs. Previous Quarter: -106.82% Sales Growth vs. Year Ago Period: 7,289.80% vs. Previous Quarter: -30.74% ROE 03/31/26 - -67.57 12/31/25 - -104.96 09/30/25 - - ROA 03/31/26 - -24.09 12/31/25 - -20.67 09/30/25 - -301.82 Current Ratio 03/31/26 - 9.90 12/31/25 - 10.33 09/30/25 - 40.03 Quick Ratio 03/31/26 - - 12/31/25 - 9.96 09/30/25 - 39.67 Operating Margin 03/31/26 - -620.84 12/31/25 - -679.54 09/30/25 - -39,358.88 Net Margin 03/31/26 - -1,427.15 12/31/25 - -679.54 09/30/25 - -39,358.88 Pre-Tax Margin 03/31/26 - -1,427.17 12/31/25 - -679.57 09/30/25 - -39,358.88 Book Value 03/31/26 - 3.39 12/31/25 - 6.88 09/30/25 - -3.78 Inventory Turnover 03/31/26 - 0.66 12/31/25 - 0.44 09/30/25 - 0.43 Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - - Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - -

Powered by Zacks Investment Research ©